Clinical trial
Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes…
NCT00465478 · Shandong University, Other · Unknown status
Key facts
| NCT number | NCT00465478 |
|---|---|
| Title | Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients |
| Official title | Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Patients With Type 1 or 2 Diabetes Mellitus-a Phase 1/2 Study |
| Lead sponsor | Shandong University, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1, Type 2 |
| Intervention type | Procedure |
| Interventions | Autologous bone marrow mononuclear cell transplantation |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Completion | Mar 1, 2014 |
| First posted | Apr 25, 2007 |
| Last update posted | Apr 25, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: